Paion AG
PA8
Hisse Senetlerindeki Sıralama
#35845
Paion AG is a specialized pharmaceutical firm engaged in the global development... Paion AG is a specialized pharmaceutical firm engaged in the global development and commercialization of medicines for hospital settings, specifically addressing needs in sedation, anesthesia, and critical care. Its primary compound, Remimazolam, is an ultra-short-acting intravenous benzodiazepine designed as a sedative/anesthetic, currently progressing through clinical trials for applications in procedural sedation, general anesthesia, and intensive care unit sedation. The company's pipeline also includes Angiotensin II, a vasoconstrictor for treating severe low blood pressure in adults experiencing septic or other forms of distributive shock, and Eravacycline, a new fluorocycline antibiotic targeting complex intra-abdominal infections in adults. Paion AG collaborates with various partners through licensing and strategic agreements, including Cosmo Pharmaceuticals, Wuhan Humanwell Innovative Drug Research and Development Center Limited Company, Hana Pharm, Yichang Humanwell, and Mundipharma. Established in 2000, Paion AG operates from Aachen, Germany.
Hisse Fiyatı
$0.42701586
Son senkronizasyon: 2023-11-01
Piyasa Değeri
$3.21M
Değişim (1 gün)
16.99%
Değişim (1 yıl)
3,114.29%
Ülke
DE
Ticaret Paion AG (PA8)
Kategori
Healthcare
Piyasa Değeri Paion AG(PA8)
Piyasa Değeri: $3.21M
October 2026 itibarıyla Paion AG şirketinin piyasa değeri $3.21M. Bu, verilerimize göre Paion AG şirketini dünyanın en değerli 35845th. şirketi yapar. Piyasa değeri, halka açık bir şirketin tedavüldeki hisse senetlerinin toplam piyasa değeri olup, bir şirketin değerini ölçmek için yaygın olarak kullanılır.
Paion AG piyasa değeri geçmişi (2023 - 2026)
En Popüler 5 stocks ile karşılaştırıldığında PA8
